irasia.com - Investor Relations Asia Pacific
HOME
Listed Companies
Search for Company
Latest Results
Financial Reports
ESG Reports
Announcements / Notices
Returns on Share Capital
Circulars
Prospectuses
Press Releases
Presentations / Webcasts
Stock Quotes
Corporate Governance
Upcoming Events
Sign Up
Seminars / Conferences
IR Services Directory
Investment Community
Resource Center
HK Statutory Notices

Neuren Pharmaceuticals Limited

Press Releases

Please download the latest "Acrobat Reader" to view the PDF.

  • 2007-February-26
    		•  Neuren Scientist Receives NZ's First Laureate Award for Scientific Excellence (in PDF)
  • 2007-February-13
    		•  Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment (in PDF)
  • 2007-January-31
    		•  US FDA Approves Neuren's Phase 3 IND for Glypromate® Trial (in PDF)
  • 2007-January-17
    		•  Neuren Reports Successful NNZ-2566 Safety Trial Results (in PDF)
  • 2006
    		•  2006 Press Releases

  • Company's Index
    		•
  • irasia.com
    		•
    About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2023 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.